Literature DB >> 17518601

Endothelial progenitor and mesenchymal stem cell-derived cells persist in tissue-engineered patch in vivo: application of green and red fluorescent protein-expressing retroviral vector.

Virna L Sales1, Bret A Mettler, Marco Lopez-Ilasaca, John A Johnson, John E Mayer.   

Abstract

An unresolved question regarding tissue-engineered (TE) cardiac valves and vessels is the fate of the transplanted cells in vivo. We have developed a strategy to track the anatomic location of seeded cells within TE constructs and neighboring tissues using a retroviral vector system encoding green and red fluorescent proteins (GFPs and RFPs, respectively) in ovine circulating endothelial progenitor cells (EPCs) and bone marrow-derived mesenchymal stem cells (BMSCs). We demonstrate that stable transduction ex vivo with high-titer Moloney murine leukemia virus-based retroviral vector yields transduction efficiency of greater than 97% GFP(+) EPC- and RFP(+) mesenchymal stem cell (MSC)-derived cells. Cellular phenotype and transgene expression were also maintained through 25 subsequent passages. Using a retroviral vector system to distinguish our pre-seeded cells from tissue-resident progenitor cells and circulating endothelial and marrow-derived precursors, we simultaneously co-seeded 2 x 10(6) GFP(+) EPCs and 2 x 10(5) RFP(+) MSCs onto the TE patches. In a series of ovine pulmonary artery patch augmentation studies, transplanted GFP(+) EPC- and RFP(+) MSC-derived cells persisted within the TE patch 7 to 14 days after implantation, as identified using immunofluorescence. Analysis showed 81% luminal coverage of the TE patches before implantation with transduced cells, increasing to 96% at day 7 and decreasing to 67% at day 14 post-implantation. This suggests a temporal association between retroviral expression of progenitor cells and mediating effects of these cells on the physiological remodeling and maturation of the TE constructs. To our knowledge, this is the first cardiovascular tissue-engineering in vivo study using a double-labeling method to demonstrate a direct evidence of the source, persistence, and incorporation into a TE vascular patch of co-cultured and simultaneously pre-seeded adult progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17518601     DOI: 10.1089/ten.2006.0128

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  12 in total

1.  Cellular behaviours of bone marrow-derived mesenchymal stem cells towards pristine graphene oxide nanosheets.

Authors:  Changbo Wei; Zifeng Liu; Fangfang Jiang; Binghui Zeng; Mingdi Huang; Dongsheng Yu
Journal:  Cell Prolif       Date:  2017-08-03       Impact factor: 6.831

2.  De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice.

Authors:  Kerstin Buttler; Muhammad Badar; Virginia Seiffart; Sandra Laggies; Gerhard Gross; Jörg Wilting; Herbert A Weich
Journal:  Cell Mol Life Sci       Date:  2013-09-01       Impact factor: 9.261

3.  Development of microfluidics as endothelial progenitor cell capture technology for cardiovascular tissue engineering and diagnostic medicine.

Authors:  Brian D Plouffe; Tatiana Kniazeva; John E Mayer; Shashi K Murthy; Virna L Sales
Journal:  FASEB J       Date:  2009-06-01       Impact factor: 5.191

4.  Quantitative assessment of neuronal differentiation in three-dimensional collagen gels using enhanced green fluorescence protein expressing PC12 pheochromocytoma cells.

Authors:  Hadar Arien-Zakay; Shimon Lecht; Anat Perets; Blair Roszell; Peter I Lelkes; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2008-07-16       Impact factor: 3.444

5.  Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.

Authors:  Anne-Laure Leblond; Patrice Naud; Virginie Forest; Clothilde Gourden; Christine Sagan; Bénédicte Romefort; Eva Mathieu; Bruno Delorme; Christine Collin; Jean-Christophe Pagès; Luc Sensebé; Bruno Pitard; Patricia Lemarchand
Journal:  Hum Gene Ther       Date:  2009-11       Impact factor: 5.695

Review 6.  Fundamentals and application of magnetic particles in cell isolation and enrichment: a review.

Authors:  Brian D Plouffe; Shashi K Murthy; Laura H Lewis
Journal:  Rep Prog Phys       Date:  2014-12-04

Review 7.  Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

8.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

9.  New technologies for surgery of the congenital cardiac defect.

Authors:  David Kalfa; Emile Bacha
Journal:  Rambam Maimonides Med J       Date:  2013-07-25

10.  Directly auto-transplanted mesenchymal stem cells induce bone formation in a ceramic bone substitute in an ectopic sheep model.

Authors:  Anja M Boos; Johanna S Loew; Gloria Deschler; Andreas Arkudas; Oliver Bleiziffer; Heinz Gulle; Adrian Dragu; Ulrich Kneser; Raymund E Horch; Justus P Beier
Journal:  J Cell Mol Med       Date:  2010-07-15       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.